Am J Transplant, Volume 17, Suppl 3 Archives - Page 181 of 181 - ATC Abstracts

2017 American Transplant Congress
Differential Effect of Antibody Removal on ABO Blood Group Type Chain Specific Antibodies Over Time.
A. Bentall,¹ M. Jeyakanthan,² J. Pearcey,² B. Motyka,² C. Cairo,³ T. Lowary,³ J. Buriak,⁴ L. West,² S. Ball.¹
¹Department of Nephrology, University Hospital Birmingham, Birmingham, United Kingdom; ²Departs of Pediatrics, Surgery and Immunology, University of Alberta, Alberta Transplant Institute, Edmonton, Canada; ³Alberta Glycomics Centre, Univ of Alberta, Dept of Chemistry, Edmonton, Canada; ⁴Dept of Chemistry, National Institute of Nanotechnology, Edmonton, Canada
Introduction: The trisaccharide epitope defines A&B blood group antigens where antibody binds to subtype chains (I-VI), but only subtype II is expressed on cardiac vascular…
2017 American Transplant Congress
What Are “Normal” CSF Findings in the Non-Infected Brain Dead Organ Donor?
R. Steiner,^1,2 C. Wainaina,² J. Tragaser,² L. Stocks.²
¹Medicine, University of California at San Diego School of Medicine, San Diego, CA; ²Lifesharing Organ Procurement Organization, San Diego, CA
Abnormalities in CSF in deceased organ donors may suggest infection and lead to refusal of organs by transplant centers, particularly if a viral process is…
2017 American Transplant Congress
Use of Pulsatile Perfusion Modifies the Effect of Delayed Graft Function on Graft Failure.
A. Thomas, A. Shaffer, A. Massie, D. Segev.
JHU, Baltimore
While the causal mechanisms remain elusive, delayed graft function (DGF) has been associated with graft failure in recipients of deceased-donor kidneys. Pulsatile perfusion pump use…
2017 American Transplant Congress
Ethnicity and Transplant Knowledge Among Canadian ESKD Patients.
D. Wong,¹ H. Ford,¹ C. Lok,¹ G. Nesrallah,² J. Peipert,³ C. Richardson,¹ A. Waterman,³ M. Novak,¹ I. Mucsi.¹
¹University Health Network, Toronto, ON, Canada; ²Humber River Hospital, Toronto, ON, Canada; ³David Geffen School of Medicine, UCLA, Los Angeles, CA
Background:Living donor kidney transplant (LDKT) offers improved life expectancy and better quality of life compared to deceased donor kidney transplant (DDKT) or dialysis. African and…
2017 American Transplant Congress
HLA Alloimmunization According to the Different Immunization Events and Consequences on Access to Kidney Transplantation.
V. Pernin,¹ A. Cros,¹ I. Szwarc,¹ C. Rene,² J.-F. Eliaou,² V. Garrigue,¹ G. Mourad,¹ M. Le Quintrec-Donnette.¹
¹Department Nephrology and Transplantation, CHU Lapeyronie, Montpellier, France; ²Department of Immunology, CHU St ELoi, Montpellier, France
Patients awaiting solid organ transplantation may develop anti-HLA antibodies after sensitization events such as transfusions, pregnancies or previous transplantations. The aim of our work was…
2017 American Transplant Congress
Can We Successfully Overcome Obesity as a Barrier for Kidney Transplantation?
K. Zorbas,¹ S. Karhadkar,¹ S. Rao,² K. Lau,¹ I. Lee,² A. Gillespie,² S. Constantinescu,² A. Karachristos,¹ A. Di Carlo.¹
¹Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA; ²Nephrology, Temple University, Philadelphia, PA
Obesity is a significant barrier for kidney transplantation (KT) with higher rates of denial for listing and longer listing to transplantation interval. We examined the…